Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
2d
Delcath Systems: Strong Financial Performance and Promising Outlook Justify Buy Rating
John Newman, an analyst from Canaccord Genuity, maintained the Buy rating on Delcath Systems (DCTH – Research Report). The associated price ...
2d
Pfizer’s Growth Potential and Strategic Focus Justify Buy Rating Amid Healthcare Policy Shifts
Analyst Evan Seigerman from BMO Capital maintained a Buy rating on Pfizer (PFE – Research Report) and keeping the price target at $36.00.Stay ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Los Angeles wildfire updates
California fires: How to help
Legendary broadcaster dies
To replace Rubio in Senate
Asks Trump for help
Accused of sexual assault
US recovers $31 million
Texas sheriff's deputy killed
Denied bail by NY judge
Doctor sentenced for abuse
Pentagon faults secrecy
France extradites US suspect
Kilauea eruption in Hawaii
2 men jailed for Wactor case
SC jail federal report
Launches DNC chair bid
Assets hit record $11.6T
Reaches orbit on first flight
FTC sues Deere & Co.
Replaced as LIV Golf CEO
Population projections drop
Google’s largest carbon deal
UK's Starmer in Kyiv
To be disbanded
Biden’s cyber defense order
Falls, injures arm
Weekly jobless claims rise
Feedback